𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Molecular genetic abnormalities in the pathogenesis of human lung cancer

✍ Scribed by Eva Forgacs; Sabine Zöchbauer-Müller; Edit Oláh; John D. Minna

Publisher
Springer Netherlands
Year
2001
Tongue
English
Weight
852 KB
Volume
7
Category
Article
ISSN
1219-4956

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Transcription factors and recessive onco
Transcription factors and recessive oncogenes in the pathogenesis of human lung cancer
✍ John D. Minna; Jochen Schütte; Jean Viallet; François Thomas; Frederic J. Kaye; 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 French ⚖ 421 KB 👁 1 views

Expression of the jun family of transcription factorslproto-oncogenes in lung cancer From recent studies it is now clear that the product of the cellular counterpart of the oncogene jun (Maki et al., 1987) is one of the proteins making up the transcription-factor preparation AP-1 (Angel et al., 198

Genetic abnormalities in plasma DNA of p
Genetic abnormalities in plasma DNA of patients with lung cancer and other respiratory diseases
✍ Sarah Khan; Judy M. Coulson; Penella J. Woll 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 117 KB

## Abstract The detection of tumour‐associated genetic alterations in plasma DNA has been proposed as a simple method for the early diagnosis of lung cancer and for identifying individuals at high risk of lung cancer who might be included in screening or chemoprevention programmes. To evaluate the

Molecular cloning of human TAK1 and its
Molecular cloning of human TAK1 and its mutational analysis in human lung cancer
✍ Masashi Kondo; Hirotaka Osada; Kosaku Uchida; Kiyoshi Yanagisawa; Akira Masuda; 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 158 KB 👁 2 views

In previous reports, we described that DPC4/Smad4 and Smad2 are mutated in a fraction of human lung cancers and suggested possible roles of the downstream mediators of transforming growth factor-␤ (TGF-␤)-elicited signals in the pathogenesis of this most common cancer. In the present study, we inves